These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 7862919)

  • 1. Dynamics of behavioral sensitization induced by the dopamine agonist quinpirole and a proposed central energy control mechanism.
    Szechtman H; Talangbayan H; Canaran G; Dai H; Eilam D
    Psychopharmacology (Berl); 1994 Jun; 115(1-2):95-104. PubMed ID: 7862919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of clorgyline on sensitization to quinpirole in rats tested in small and large environments.
    Dvorkin A; Culver KE; Szechtman H
    Psychopharmacology (Berl); 2006 Jul; 186(4):534-43. PubMed ID: 16758240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A switch mechanism between locomotion and mouthing implicated in sensitization to quinpirole in rats.
    Culver KE; Rosenfeld JM; Szechtman H
    Psychopharmacology (Berl); 2000 Aug; 151(2-3):202-10. PubMed ID: 10972466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clorgyline-induced switch from locomotion to mouthing in sensitization to the dopamine D2/D3 agonist quinpirole in rats: role of sigma and imidazoline I2 receptors.
    Culver KE; Szechtman H
    Psychopharmacology (Berl); 2003 May; 167(2):211-8. PubMed ID: 12652347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypophysectomy does not block sensitization to the dopamine agonist quinpirole or its modulation by the MAOI clorgyline.
    Culver KE; Szechtman H
    Horm Behav; 2004 Jan; 45(1):23-30. PubMed ID: 14733888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitization of amphetamine-induced stereotyped behaviors during the acute response: role of D1 and D2 dopamine receptors.
    Kuczenski R; Segal DS
    Brain Res; 1999 Mar; 822(1-2):164-74. PubMed ID: 10082894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dosing regimen differentiates sensitization of locomotion and mouthing to D2 agonist quinpirole.
    Eilam D; Szechtman H
    Pharmacol Biochem Behav; 1990 Aug; 36(4):989-91. PubMed ID: 1977180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of stereotyped behavior and production of latent locomotor behaviors in mice treated continuously with quinpirole.
    Zhou LW; Qin ZH; Weiss B
    Neuropsychopharmacology; 1991 Jan; 4(1):47-55. PubMed ID: 1672250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and temporal organization of compulsive checking induced by repeated injections of the dopamine agonist quinpirole in an animal model of obsessive-compulsive disorder.
    Dvorkin A; Perreault ML; Szechtman H
    Behav Brain Res; 2006 May; 169(2):303-11. PubMed ID: 16524632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perseveration without hyperlocomotion in a spontaneous alternation task in rats sensitized to the dopamine agonist quinpirole.
    Einat H; Szechtman H
    Physiol Behav; 1995 Jan; 57(1):55-9. PubMed ID: 7878126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in gut microbiota during development of compulsive checking and locomotor sensitization induced by chronic treatment with the dopamine agonist quinpirole.
    Jung TD; Jung PS; Raveendran L; Farbod Y; Dvorkin-Gheva A; Sakic B; Surette MG; Szechtman H
    Behav Pharmacol; 2018 Apr; 29(2 and 3-Spec Issue):211-224. PubMed ID: 29194070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopaminergic control of locomotion, mouthing, snout contact, and grooming: opposing roles of D1 and D2 receptors.
    Eilam D; Talangbayan H; Canaran G; Szechtman H
    Psychopharmacology (Berl); 1992; 106(4):447-54. PubMed ID: 1533720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoamine oxidase inhibitor-induced blockade of locomotor sensitization to quinpirole: role of striatal dopamine uptake inhibition.
    Culver KE; Rosenfeld JM; Szechtman H
    Neuropharmacology; 2002 Sep; 43(3):385-93. PubMed ID: 12243768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in behavioral sensitivity to SKF-38393 and quinpirole following withdrawal from continuous cocaine administration in rats.
    Neisewander JL; Lucki I; McGonigle P
    Pharmacol Biochem Behav; 1996 Apr; 53(4):935-42. PubMed ID: 8801600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of dose and interdose interval on locomotor sensitization to the dopamine agonist quinpirole.
    Szechtman H; Dai H; Mustafa S; Einat H; Sullivan RM
    Pharmacol Biochem Behav; 1994 Aug; 48(4):921-8. PubMed ID: 7972297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A dose-response study of separate and combined effects of the serotonin agonist 8-OH-DPAT and the dopamine agonist quinpirole on locomotor sensitization, cross-sensitization, and conditioned activity.
    Johnson EF; Szechtman H
    Behav Pharmacol; 2016 Aug; 27(5):439-50. PubMed ID: 26871406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of SKF-38393, a dopamine D1 receptor agonist on expression of amphetamine-induced behavioral sensitization and expression of immediate early gene arc in prefrontal cortex of rats.
    Moro H; Sato H; Ida I; Oshima A; Sakurai N; Shihara N; Horikawa Y; Mikuni M
    Pharmacol Biochem Behav; 2007 May; 87(1):56-64. PubMed ID: 17499349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of altered whole-body metabolism with locomotor sensitization induced by quinpirole.
    Coscina DV; Currie PJ; Szechtman H
    Physiol Behav; 1998 Mar; 63(5):755-61. PubMed ID: 9617996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repeated stimulation of D1 dopamine receptors causes time-dependent alterations in the sensitivity of both D1 and D2 dopamine receptors within the rat striatum.
    Hu XT; Brooderson RJ; White FJ
    Neuroscience; 1992 Sep; 50(1):137-47. PubMed ID: 1357592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kappa-opioid receptor stimulation quickens pathogenesis of compulsive checking in the quinpirole sensitization model of obsessive-compulsive disorder (OCD).
    Perreault ML; Seeman P; Szechtman H
    Behav Neurosci; 2007 Oct; 121(5):976-91. PubMed ID: 17907829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.